Ethris Competitors and Similar CompaniesClear all
Ethris's competitors and similar companies include Ambrx and Asklepios BioPharmaceutical.
 Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. | |
Founding Date | Founding Date 2009 | Founding Date 2003 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Planegg, DE HQ | Locations San Diego, US HQ | Locations Chapel Hill, US HQ Roslin, GB |
Employees | Employees 504% decrease | Employees 70 | Employees 5172% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 347.9m | Total funding raised $ 235m |
For sources of this data, please see the company profile
View Company Profiles
Ambrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View companyAsklepios BioPharmaceutical
HQ
Chapel Hill, US
Employees
517↑ 2% increase
Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.
View company